Physician profile
Bryan D Caskey
NPI 1366582660
$3,357.69
in general payments reported to CMS, 2019-2025
17 companies · $775 in 2025
The $775 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $545 · 2022: $515 · 2023: $792 · 2024: $732 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,298.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,406.42 | 2022-2025 | Tremfya |
| Abbvie INC. | $1,044.50 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $208.40 | 2022-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $158.98 | 2021-2024 | Odomzo, Blu-U |
| Lilly USA, LLC | $143.30 | 2021-2022 | |
| Organogenesis INC. | $87.89 | 2022-2023 | Puraply |
| Janssen Scientific Affairs, LLC | $75.85 | 2021 | |
| Dermavant Sciences, INC. | $58.27 | 2023-2024 | Vtama |
| Incyte Corporation | $26.17 | 2022 | |
| Galderma Laboratories, L.P. | $23.27 | 2025 | Nemluvio |
| Pfizer INC. | $20.82 | 2023 | |
| Arcutis Biotherapeutics, INC. | $20.01 | 2025 | Zoryve |
| Genentech USA, INC. | $19.23 | 2021 | |
| Ucb, INC. | $18.33 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $17.72 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $14.41 | 2023 | Adbry |
| Biofrontera INC. | $14.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Caskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.